Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: Report of two new cases and review of the literature

Elisa Tinazzi, Antonio Puccetti, Giuseppe Patuzzo, Michele Sorleto, Alessandro Barbieri, Claudio Lunardi

Research output: Contribution to journalArticle

Abstract

Schnitzler syndrome is a rare disorder characterized clinically by chronic urticarial rash accompanied by fever, arthralgia or arthritis, bone pain and lymphoadenopathy and biochemically by monoclonal gammopathy and elevation of inflammatory indices. The disorder is very likely under-recognized and its origin remains obscure although it may be included among the immune mediated inflammatory diseases with features of autoinflammation and autoimmunity.We describe here two patients affected by Schnitzler syndrome, both refractory to corticosteroids and immunosuppressive therapy, successfully treated with the interleukin-1 receptor antagonist Anakinra. Unfortunately after two weeks, one patient experienced an important local adverse reaction to the biological drug. We decided to discontinue Anakinra with flare of the disease after 24. h. We therefore switched to Rituximab obtaining a complete remission in two months.We searched MEDLINE in order to analyze the frequency of the disease, its pathogenesis and outcome. The electronic search was conducted using the following key words "Schnitzler syndrome" and "Treatment of Schnitzler syndrome". All the selected papers, except the clinical reviews, described at least one case of Schnitzler syndrome. The review of the literature highlighted that Schnitzler syndrome remains an enigmatic disorder hard to categorize and to treat.

Original languageEnglish
Pages (from-to)404-409
Number of pages6
JournalAutoimmunity Reviews
Volume10
Issue number7
DOIs
Publication statusPublished - May 2011

Fingerprint

Schnitzler Syndrome
Interleukin 1 Receptor Antagonist Protein
Paraproteinemias
Interleukin-1 Receptors
Arthralgia
Immunosuppressive Agents
Exanthema
Autoimmunity
MEDLINE
Arthritis
Adrenal Cortex Hormones
Fever
Bone and Bones
Pain
Therapeutics

Keywords

  • Anti-CD20, Rituximab
  • Autoimmune/autoinflammatory disorder
  • IL-1? receptor inhibitor, Anakinra
  • Schnitzler syndrome

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Schnitzler syndrome, an autoimmune-autoinflammatory syndrome : Report of two new cases and review of the literature. / Tinazzi, Elisa; Puccetti, Antonio; Patuzzo, Giuseppe; Sorleto, Michele; Barbieri, Alessandro; Lunardi, Claudio.

In: Autoimmunity Reviews, Vol. 10, No. 7, 05.2011, p. 404-409.

Research output: Contribution to journalArticle

Tinazzi, Elisa ; Puccetti, Antonio ; Patuzzo, Giuseppe ; Sorleto, Michele ; Barbieri, Alessandro ; Lunardi, Claudio. / Schnitzler syndrome, an autoimmune-autoinflammatory syndrome : Report of two new cases and review of the literature. In: Autoimmunity Reviews. 2011 ; Vol. 10, No. 7. pp. 404-409.
@article{4e51003f0f1343a59ee0a9bafcdf4463,
title = "Schnitzler syndrome, an autoimmune-autoinflammatory syndrome: Report of two new cases and review of the literature",
abstract = "Schnitzler syndrome is a rare disorder characterized clinically by chronic urticarial rash accompanied by fever, arthralgia or arthritis, bone pain and lymphoadenopathy and biochemically by monoclonal gammopathy and elevation of inflammatory indices. The disorder is very likely under-recognized and its origin remains obscure although it may be included among the immune mediated inflammatory diseases with features of autoinflammation and autoimmunity.We describe here two patients affected by Schnitzler syndrome, both refractory to corticosteroids and immunosuppressive therapy, successfully treated with the interleukin-1 receptor antagonist Anakinra. Unfortunately after two weeks, one patient experienced an important local adverse reaction to the biological drug. We decided to discontinue Anakinra with flare of the disease after 24. h. We therefore switched to Rituximab obtaining a complete remission in two months.We searched MEDLINE in order to analyze the frequency of the disease, its pathogenesis and outcome. The electronic search was conducted using the following key words {"}Schnitzler syndrome{"} and {"}Treatment of Schnitzler syndrome{"}. All the selected papers, except the clinical reviews, described at least one case of Schnitzler syndrome. The review of the literature highlighted that Schnitzler syndrome remains an enigmatic disorder hard to categorize and to treat.",
keywords = "Anti-CD20, Rituximab, Autoimmune/autoinflammatory disorder, IL-1? receptor inhibitor, Anakinra, Schnitzler syndrome",
author = "Elisa Tinazzi and Antonio Puccetti and Giuseppe Patuzzo and Michele Sorleto and Alessandro Barbieri and Claudio Lunardi",
year = "2011",
month = "5",
doi = "10.1016/j.autrev.2011.01.003",
language = "English",
volume = "10",
pages = "404--409",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "7",

}

TY - JOUR

T1 - Schnitzler syndrome, an autoimmune-autoinflammatory syndrome

T2 - Report of two new cases and review of the literature

AU - Tinazzi, Elisa

AU - Puccetti, Antonio

AU - Patuzzo, Giuseppe

AU - Sorleto, Michele

AU - Barbieri, Alessandro

AU - Lunardi, Claudio

PY - 2011/5

Y1 - 2011/5

N2 - Schnitzler syndrome is a rare disorder characterized clinically by chronic urticarial rash accompanied by fever, arthralgia or arthritis, bone pain and lymphoadenopathy and biochemically by monoclonal gammopathy and elevation of inflammatory indices. The disorder is very likely under-recognized and its origin remains obscure although it may be included among the immune mediated inflammatory diseases with features of autoinflammation and autoimmunity.We describe here two patients affected by Schnitzler syndrome, both refractory to corticosteroids and immunosuppressive therapy, successfully treated with the interleukin-1 receptor antagonist Anakinra. Unfortunately after two weeks, one patient experienced an important local adverse reaction to the biological drug. We decided to discontinue Anakinra with flare of the disease after 24. h. We therefore switched to Rituximab obtaining a complete remission in two months.We searched MEDLINE in order to analyze the frequency of the disease, its pathogenesis and outcome. The electronic search was conducted using the following key words "Schnitzler syndrome" and "Treatment of Schnitzler syndrome". All the selected papers, except the clinical reviews, described at least one case of Schnitzler syndrome. The review of the literature highlighted that Schnitzler syndrome remains an enigmatic disorder hard to categorize and to treat.

AB - Schnitzler syndrome is a rare disorder characterized clinically by chronic urticarial rash accompanied by fever, arthralgia or arthritis, bone pain and lymphoadenopathy and biochemically by monoclonal gammopathy and elevation of inflammatory indices. The disorder is very likely under-recognized and its origin remains obscure although it may be included among the immune mediated inflammatory diseases with features of autoinflammation and autoimmunity.We describe here two patients affected by Schnitzler syndrome, both refractory to corticosteroids and immunosuppressive therapy, successfully treated with the interleukin-1 receptor antagonist Anakinra. Unfortunately after two weeks, one patient experienced an important local adverse reaction to the biological drug. We decided to discontinue Anakinra with flare of the disease after 24. h. We therefore switched to Rituximab obtaining a complete remission in two months.We searched MEDLINE in order to analyze the frequency of the disease, its pathogenesis and outcome. The electronic search was conducted using the following key words "Schnitzler syndrome" and "Treatment of Schnitzler syndrome". All the selected papers, except the clinical reviews, described at least one case of Schnitzler syndrome. The review of the literature highlighted that Schnitzler syndrome remains an enigmatic disorder hard to categorize and to treat.

KW - Anti-CD20, Rituximab

KW - Autoimmune/autoinflammatory disorder

KW - IL-1? receptor inhibitor, Anakinra

KW - Schnitzler syndrome

UR - http://www.scopus.com/inward/record.url?scp=79955079206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955079206&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2011.01.003

DO - 10.1016/j.autrev.2011.01.003

M3 - Article

C2 - 21256251

AN - SCOPUS:79955079206

VL - 10

SP - 404

EP - 409

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 7

ER -